138 related articles for article (PubMed ID: 11142522)
1. Prospects for nutritional interventions in the clinical management of Fanconi anemia.
Pagano G; Korkina LG
Cancer Causes Control; 2000 Dec; 11(10):881-9. PubMed ID: 11142522
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.
Pagano G
Carcinogenesis; 2000 May; 21(5):1067-8. PubMed ID: 10783335
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype.
Pagano G; Degan P; d'Ischia M; Kelly FJ; Nobili B; Pallardó FV; Youssoufian H; Zatterale A
Eur J Haematol; 2005 Aug; 75(2):93-100. PubMed ID: 16000125
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management.
Pagano G; Talamanca AA; Castello G; Pallardó FV; Zatterale A; Degan P
Biol Chem; 2012 Jan; 393(1-2):11-21. PubMed ID: 22628295
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic differentiation of Fanconi anemia, "idiopathic" aplastic anemia, and Fanconi anemia heterozygotes.
Cervenka J; Hirsch BA
Am J Med Genet; 1983 Jun; 15(2):211-23. PubMed ID: 6410915
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane.
Ruppitsch W; Meisslitzer C; Hirsch-Kauffmann M; Schweiger M
FEBS Lett; 1998 Jan; 422(1):99-102. PubMed ID: 9475178
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.
Pagano G; d'Ischia M; Pallardó FV
Pediatr Blood Cancer; 2015 Jul; 62(7):1137-43. PubMed ID: 25732180
[TBL] [Abstract][Full Text] [Related]
8. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia.
Mukhopadhyay SS; Leung KS; Hicks MJ; Hastings PJ; Youssoufian H; Plon SE
J Cell Biol; 2006 Oct; 175(2):225-35. PubMed ID: 17060495
[TBL] [Abstract][Full Text] [Related]
9. Redox-modulated xenobiotic action and ROS formation: a mirror or a window?
Pagano G
Hum Exp Toxicol; 2002 Feb; 21(2):77-81. PubMed ID: 12102500
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience.
Altay C; Alikaşifoglu M; Kara A; Tunçbilek E; Ozbek N; Schroeder-Kurth TM
Clin Genet; 1997 May; 51(5):296-302. PubMed ID: 9212176
[TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia and its diagnosis.
Auerbach AD
Mutat Res; 2009 Jul; 668(1-2):4-10. PubMed ID: 19622403
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia screening by diepoxybutane and mitomicin C tests in Korean children with bone marrow failure syndromes.
Kook H; Cho D; Cho SH; Hong WP; Kim CJ; Park JY; Yoon WS; Ryang DW; Hwang TJ
J Korean Med Sci; 1998 Dec; 13(6):623-8. PubMed ID: 9886171
[TBL] [Abstract][Full Text] [Related]
13. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
Korgaonkar S; Ghosh K; Vundinti BR
Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of single-cell gel electrophoresis and mitomycin C-induced chromosomal breakage for chromosomal instabiligy in children with Fanconi anemia].
Zhang L; Liu Q; Zou Y; Liu XM; Zhang JY; Wang SC; Chen XJ; Guo Y; Yang WY; Ruan M; Liu TF; Liu F; Cai XJ; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):122-5. PubMed ID: 23527978
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Fanconi anemia by diepoxybutane analysis.
Auerbach AD
Curr Protoc Hum Genet; 2015 Apr; 85():8.7.1-8.7.17. PubMed ID: 25827349
[TBL] [Abstract][Full Text] [Related]
16. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
[TBL] [Abstract][Full Text] [Related]
17. The identification of fanconi anemia genotypes by clastogenic stress.
Cohen MM; Simpson SJ; Honig GR; Maurer HS; Nicklas JW; Martin AO
Am J Hum Genet; 1982 Sep; 34(5):794-810. PubMed ID: 6812413
[TBL] [Abstract][Full Text] [Related]
18. DEB test for Fanconi anemia detection in patients with atypical phenotypes.
Esmer C; Sánchez S; Ramos S; Molina B; Frias S; Carnevale A
Am J Med Genet A; 2004 Jan; 124A(1):35-9. PubMed ID: 14679584
[TBL] [Abstract][Full Text] [Related]
19. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.
Castella M; Pujol R; Callén E; Ramírez MJ; Casado JA; Talavera M; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Estella J; Dasí Á; Rodríguez-Villa A; Gómez P; Tapia M; Molinés A; Figuera Á; Bueren JA; Surrallés J
J Med Genet; 2011 Apr; 48(4):242-50. PubMed ID: 21217111
[TBL] [Abstract][Full Text] [Related]
20. Fanconi's anemia--chromosome breakage studies in homozygotes and heterozygotes.
Rosendorff J; Bernstein R
Cancer Genet Cytogenet; 1988 Jul; 33(2):175-83. PubMed ID: 3133104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
